MAPT and Alzheimer disease: Assessment of t-tau/Aβ42 in serum was also conducted by Park et al. Authors of this study did not provide a comparison among groups (AD, MCI, HC), but they were searching for a correlation of acquired biomarkers ratio to existence or non-existence of tau protein deposits by the use of PET.